Selpercatinib in Early-Stage RET Fusion–Positive Non–Small-Cell Lung Cancer - Yi-Long Wu; Maximilian Hochmair; Yi Yang; Xue-Ning Yang; Masahiro Tsuboi; Luis Paz-Ares; James Chih-Hsin Yang; Lin Wu; Hye Ryun Kim; Damian T. Rieke; Melissa Johnson; Benjamin Besse; et al. (New England Journal of Medicine, 2026)